A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and Chemoresistance

Yasuo Tsunetoshi, Fumihiro Sanada, Yuko Kanemoto, Kana Shibata, Atsushi Masamune, Yoshiaki Taniyama, Koichi Yamamoto, Ryuichi Morishita · 2024

Read A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and Chemoresistance by Yasuo Tsunetoshi, Fumihiro Sanada, Yuko Kanemoto, Kana Shibata, Atsushi Masamune, Yoshiaki Taniyama, Koichi Yamamoto, Ryuichi Morishita (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641934.txt.

Description

Pancreatic cancer hides in a dense scar-like stroma, and one stroma protein's altered forms may shield it from drugs. Yasuo Tsunetoshi and co-authors study those forms in a 2024 paper. The protein, periostin, is made mostly by cancer-linked fibroblasts around the tumor. One spliced form carrying a certain exon appears in both mouse and human tumors. Gene reading tied periostin-rich fibroblasts to matrix and signal genes.

Only the altered form grips a heat-shock partner protein. That grip rescued tumor cells from a standard drug's killing effect. Computer models show the exon changes the protein's shape and grip sites. The authors frame the form as a driver of drug resistance.

Catalog record

CREATORYasuo Tsunetoshi, Fumihiro Sanada, Yuko Kanemoto, Kana Shibata, Atsushi Masamune, Yoshiaki Taniyama, Koichi Yamamoto, Ryuichi Morishita
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11641934

Browse the full library · About the Tower of Babel